13.10
Finanzdaten der Oric Pharmaceuticals Inc-Aktie (ORIC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
| Operating Expenses |
19.40%
39.06
|
32.72 | 39.57 | 38.32 | 36.02 |
| Operating Income/Loss |
19.40%
-39.06
|
-32.72 | -39.57 | -38.32 | -36.02 |
| Nonoperating Income/Loss |
0.44%
2.709
|
2.697 | 3.263 | 3.752 | 4.054 |
| Income/Loss From Continuing Operations Before Tax |
21.10%
-36.35
|
-30.02 | -36.31 | -34.57 | -31.96 |
| Income/Loss From Continuing Operations After Tax |
21.10%
-36.35
|
-30.02 | -36.31 | -34.57 | -31.96 |
|
|
21.10%
-36.35
|
-30.02 | -36.31 | -34.57 | -31.96 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
9.97%
78.13
|
71.04 | 0.3103 | 70.54 | 70.35 |
| Diluted Average Shares |
9.97%
78.13
|
71.04 | 0.3103 | 70.54 | 70.35 |
| Basic Earnings Per Share |
11.90%
-0.47
|
-0.42 | -0.51 | -0.49 | -0.45 |
| Diluted Earnings Per Share |
11.90%
-0.47
|
-0.42 | -0.51 | -0.49 | -0.45 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):